Menopausal Transition Linked to Adverse Changes in Lipoprotein Profile
By Elana Gotkine HealthDay Reporter
FRIDAY, Aug. 30, 2024 -- Menopausal status is associated with adverse changes in lipoprotein profiles, according to a study presented at the European Society of Cardiology Congress 2024, held from Aug. 30 to Sept. 2 in London.
Stephanie Moreno, M.D., from the University of Texas Southwestern in Dallas, and colleagues examined changes in lipid measures through the menopause transition using data from the Dallas Heart Study (DHS). Women with known menopausal status who underwent nuclear magnetic resonance LipoProfile lipid platform analysis at DHS-I and DHS-II were included. Data were analyzed for 440 premenopausal women, 298 perimenopausal women, 508 postmenopausal women, and 1,364 men.
The researchers found that women experienced a greater change in low-density lipoprotein (LDL) particles from DHS-I to DHS-II compared with men; premenopausal and perimenopausal women had the greatest change. Compared with men, postmenopausal women had a greater reduction in high-density lipoprotein (HDL) particles between DHS-I and DHS-II. Greater change in small-dense LDL was seen for women versus men, with the most pronounced changes in perimenopausal women. Significantly greater reductions in large HDL were seen in perimenopausal and postmenopausal women compared with men; no difference was seen in the change in large HDL between premenopausal women and men.
"We found that menopause is associated with adverse changes in lipoprotein profiles, with the most pronounced changes found to be in increases in 'bad' LDL-particles and subfractions observed for perimenopausal women," Moreno said in a statement. "When looked at together, these changes could help explain the increase of cardiovascular disease in postmenopausal women and help determine if earlier interventions are warranted."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2024
Read this next
Hormone Therapy Tied to Less Biological Aging in Postmenopausal Women
TUESDAY, Sept. 3, 2024 -- Postmenopausal women who use hormone therapy (HT) are biologically younger than those not receiving HT, according to a study published online Aug. 29...
Inflammation, Cholesterol, Lipoprotein(a) Predict 30-Year Cardiovascular Outcomes in Women
TUESDAY, Sept. 3, 2024 -- A single combined measure of high-sensitivity C-reactive protein (CRP), low-density lipoprotein (LDL) cholesterol, and lipoprotein(a) levels predict the...
Elinzanetant Efficacious, Well-Tolerated for Vasomotor Symptoms
TUESDAY, Aug. 27, 2024 -- For menopausal vasomotor symptoms (VMS), elinzanetant is efficacious and well-tolerated, according to a study published online Aug. 22 in the Journal of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.